Alsonosi A, Hariri S, Kajsík M, Oriešková M, Hanulík V, Röderová M, Petrželová J, Kollárová H, Drahovská H, Forsythe S, Holý O
Pathogen Research Group, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham, NG11 8NS, UK.
Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia.
Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):1979-88. doi: 10.1007/s10096-015-2440-8. Epub 2015 Jul 15.
The World Health Organization (WHO) has recognised all Cronobacter species as human pathogens. Among premature neonates and immunocompromised infants, these infections can be life-threatening, with clinical presentations of septicaemia, meningitis and necrotising enterocolitis. The neurological sequelae can be permanent and the mortality rate as high as 40-80%. Despite the highlighted issues of neonatal infections, the majority of Cronobacter infections are in the elderly population suffering from serious underlying disease or malignancy and include wound and urinary tract infections, osteomyelitis, bacteraemia and septicaemia. However, no age profiling studies have speciated or genotyped the Cronobacter isolates. A clinical collection of 51 Cronobacter strains from two hospitals were speciated and genotyped using 7-loci multilocus sequence typing (MLST), rpoB gene sequence analysis, O-antigen typing and pulsed-field gel electrophoresis (PFGE). The isolates were predominated by C. sakazakii sequence type 4 (63%, 32/51) and C. malonaticus sequence type 7 (33%, 17/51). These had been isolated from throat and sputum samples of all age groups, as well as recal and faecal swabs. There was no apparent relatedness between the age of the patient and the Cronobacter species isolated. Despite the high clonality of Cronobacter, PFGE profiles differentiated strains across the sequence types into 15 pulsotypes. There was almost complete agreement between O-antigen typing and rpoB gene sequence analysis and MLST profiling. This study shows the value of applying MLST to bacterial population studies with strains from two patient cohorts, combined with PFGE for further discrimination of strains.
世界卫生组织(WHO)已将所有阪崎肠杆菌属物种认定为人类病原体。在早产儿和免疫功能低下的婴儿中,这些感染可能危及生命,临床表现为败血症、脑膜炎和坏死性小肠结肠炎。神经后遗症可能是永久性的,死亡率高达40%-80%。尽管新生儿感染问题备受关注,但大多数阪崎肠杆菌感染发生在患有严重基础疾病或恶性肿瘤的老年人群中,包括伤口感染、尿路感染、骨髓炎、菌血症和败血症。然而,尚无年龄分布研究对阪崎肠杆菌分离株进行物种鉴定或基因分型。使用7位点多位点序列分型(MLST)、rpoB基因序列分析、O抗原分型和脉冲场凝胶电泳(PFGE),对来自两家医院的51株阪崎肠杆菌临床菌株进行了物种鉴定和基因分型。分离株以阪崎肠杆菌序列型4为主(63%,32/51),其次是阪崎肠杆菌序列型7(33%,17/51)。这些菌株从所有年龄组的咽喉和痰液样本以及直肠和粪便拭子中分离得到。患者年龄与分离出的阪崎肠杆菌物种之间没有明显的相关性。尽管阪崎肠杆菌的克隆性很高,但PFGE图谱将不同序列类型的菌株分为15个脉冲型。O抗原分型、rpoB基因序列分析和MLST图谱之间几乎完全一致。本研究显示了将MLST应用于两个患者队列菌株的细菌群体研究,并结合PFGE进一步区分菌株的价值。